NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,160 filers reported holding NOVARTIS A G in Q1 2023. The put-call ratio across all filers is 0.47 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $653 | -10.3% | 6,424 | -11.1% | 0.00% | 0.0% |
| Q2 2023 | $728 | +22.1% | 7,224 | +11.3% | 0.00% | 0.0% |
| Q1 2023 | $596 | 0.0% | 6,489 | -1.2% | 0.00% | 0.0% |
| Q4 2022 | $596 | -99.9% | 6,571 | -17.2% | 0.00% | 0.0% |
| Q3 2022 | $602,000 | -38.4% | 7,938 | -31.5% | 0.00% | 0.0% |
| Q2 2022 | $978,000 | -99.0% | 11,583 | -99.0% | 0.00% | -99.1% |
| Q1 2022 | $98,246,000 | -1.8% | 1,119,623 | -2.1% | 0.11% | +7.5% |
| Q4 2021 | $100,042,000 | +8.7% | 1,143,745 | +1.7% | 0.11% | +1.9% |
| Q3 2021 | $92,013,000 | -11.4% | 1,125,140 | -1.1% | 0.10% | -11.1% |
| Q2 2021 | $103,845,000 | +6.9% | 1,138,164 | +0.2% | 0.12% | -0.8% |
| Q1 2021 | $97,100,000 | -31.0% | 1,135,941 | -23.8% | 0.12% | -33.7% |
| Q4 2020 | $140,762,000 | -13.2% | 1,490,654 | -20.1% | 0.18% | -21.9% |
| Q3 2020 | $162,220,000 | -21.8% | 1,865,460 | -21.4% | 0.23% | -28.5% |
| Q2 2020 | $207,348,000 | -6.6% | 2,374,041 | -11.8% | 0.32% | -21.6% |
| Q1 2020 | $221,914,000 | -5.2% | 2,691,510 | +8.8% | 0.41% | +21.9% |
| Q4 2019 | $234,139,000 | +8.1% | 2,472,697 | -0.8% | 0.33% | -6.2% |
| Q3 2019 | $216,547,000 | -5.2% | 2,491,912 | -0.4% | 0.36% | -4.0% |
| Q2 2019 | $228,528,000 | -5.9% | 2,502,779 | -0.9% | 0.37% | -6.5% |
| Q1 2019 | $242,839,000 | +15.6% | 2,525,897 | +3.2% | 0.40% | +2.6% |
| Q4 2018 | $209,989,000 | +30.5% | 2,447,150 | +31.0% | 0.39% | +48.8% |
| Q3 2018 | $160,950,000 | +16.9% | 1,868,047 | +2.5% | 0.26% | +8.8% |
| Q2 2018 | $137,698,000 | -5.1% | 1,822,853 | +1.6% | 0.24% | -3.6% |
| Q1 2018 | $145,116,000 | +3.2% | 1,794,883 | +7.2% | 0.25% | +2.9% |
| Q4 2017 | $140,590,000 | +3.5% | 1,674,499 | +5.8% | 0.24% | -2.0% |
| Q3 2017 | $135,828,000 | +3.9% | 1,582,164 | +1.1% | 0.25% | 0.0% |
| Q2 2017 | $130,679,000 | +13.6% | 1,565,598 | +1.1% | 0.25% | +13.4% |
| Q1 2017 | $115,043,000 | -27.9% | 1,548,987 | -29.2% | 0.22% | -33.2% |
| Q4 2016 | $159,470,000 | -14.4% | 2,189,337 | -7.2% | 0.32% | -12.2% |
| Q3 2016 | $186,310,000 | -0.6% | 2,359,559 | +3.9% | 0.37% | -6.3% |
| Q2 2016 | $187,450,000 | +15.6% | 2,271,846 | +1.5% | 0.40% | +11.6% |
| Q1 2016 | $162,157,000 | -18.1% | 2,238,512 | -2.7% | 0.35% | -21.9% |
| Q4 2015 | $197,902,000 | -6.0% | 2,300,116 | +0.4% | 0.45% | -9.9% |
| Q3 2015 | $210,574,000 | -4.0% | 2,290,849 | +2.7% | 0.50% | +9.3% |
| Q2 2015 | $219,352,000 | +4.6% | 2,230,556 | +4.9% | 0.46% | +1.8% |
| Q1 2015 | $209,653,000 | +10.3% | 2,126,084 | +3.6% | 0.45% | +11.3% |
| Q4 2014 | $190,155,000 | -1.6% | 2,052,183 | -0.1% | 0.41% | -2.2% |
| Q3 2014 | $193,276,000 | +0.9% | 2,053,293 | -2.9% | 0.42% | +3.8% |
| Q2 2014 | $191,472,000 | +10.8% | 2,115,018 | +4.1% | 0.40% | +3.6% |
| Q1 2014 | $172,781,000 | +15.9% | 2,032,245 | +9.5% | 0.39% | +16.6% |
| Q4 2013 | $149,120,000 | +7.9% | 1,855,198 | +3.0% | 0.33% | +0.9% |
| Q3 2013 | $138,175,000 | +10.2% | 1,801,264 | +1.6% | 0.33% | +10.4% |
| Q2 2013 | $125,331,000 | – | 1,772,465 | – | 0.30% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| NEXTHERA CAPITAL LP | 198,000 | $14,422,000 | 8.45% |
| PRENTISS SMITH & CO INC | 133,202 | $9,702,000 | 5.92% |
| EXENCIAL WEALTH ADVISORS, LLC | 178,313 | $12,988,000 | 5.50% |
| MANAGED ASSET PORTFOLIOS, LLC | 185,868 | $13,538,000 | 5.33% |
| Osher Van de Voorde Investment Management | 114,735 | $8,357,000 | 4.59% |
| BROWN BROTHERS HARRIMAN & CO | 10,971,272 | $799,147,000 | 4.37% |
| PROFESSIONAL ADVISORY SERVICES INC | 238,542 | $17,375,000 | 4.04% |
| Elefante Mark B | 4,579 | $333,000 | 4.02% |
| COMPASS CAPITAL MANAGEMENT, INC | 271,536 | $19,779,000 | 3.69% |
| CGOV Asset Management | 972,731 | $95,135,000 | 3.51% |